{"id":1332,"date":"2014-11-22T21:11:18","date_gmt":"2014-11-22T21:11:18","guid":{"rendered":"http:\/\/www.wi.rwth-aachen.de\/SmartMedCN\/?p=1332"},"modified":"2014-11-22T21:11:18","modified_gmt":"2014-11-22T21:11:18","slug":"transnational-pharmaceutical-companies-low-efficiency-of-approval-perplexes-the-chinese-medicine-market","status":"publish","type":"post","link":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/2014\/11\/22\/transnational-pharmaceutical-companies-low-efficiency-of-approval-perplexes-the-chinese-medicine-market\/","title":{"rendered":"Transnational pharmaceutical companies: low efficiency of approval perplexes the Chinese medicine market"},"content":{"rendered":"<p style=\"text-align: justify\"><strong>John C. Lechleiter, the CEO of Eli Lilly, said on 10<sup>th<\/sup>, November at the APEC CEO summit that it is hard for transnational pharmaceutical companies to promote new medicine to China because of the difficulties of approval. In the other interview, Alex Gorsky, the CEO of Johnson &amp; Johnson, held the same idea. He said the average approval time for a new medicine in China is eight years, while it is four years in other countries. They think the Chinese medicine market is perplexed by the problem of supervision and low efficiency of approval and Chinese government should make more effort to reorganize the Chinese medicine market which has broad prospects.\u00a0 (Source: China News)<\/strong><\/p>\n<h3 style=\"text-align: justify\">\u8de8\u56fd\u836f\u4f01\uff1a\u5ba1\u6279\u6548\u7387\u4f4e\u4e0b\u56f0\u6270\u4e2d\u56fd\u533b\u836f\u5e02\u573a<\/h3>\n<p style=\"text-align: justify\">\u6765\u6e90\uff1a\u4e2d\u56fd\u65b0\u95fb\u7f51<\/p>\n<p style=\"text-align: justify\">\u6838\u5fc3\u63d0\u793a\uff1a\u793c\u6765\u5236\u836f\u9996\u5e2d\u6267\u884c\u5b98\u674e\u52b1\u8fbe\uff08John C. Lechleiter\uff09\u5468\u4e00\u5728\u4e9a\u592a\u7ecf\u5408\u7ec4\u7ec7\uff08APEC\uff09\u5de5\u5546\u9886\u5bfc\u4eba\u5cf0\u4f1a\u4e0a\u8868\u793a\uff0c\u7531\u4e8e\u9762\u4e34\u76d1\u7ba1\u4e0a\u7684\u91cd\u91cd\u56f0\u96be\uff0c\u56fd\u9645\u836f\u4f01\u5f88\u96be\u5c06\u521b\u65b0\u836f\u54c1\u63a8\u5411\u4e2d\u56fd\u5e02\u573a\u3002\u5728\u53e6\u5916\u4e00\u4e2a\u91c7\u8bbf\u4e2d\uff0c\u5f3a\u751f\u9996\u5e2d\u6267\u884c\u5b98\u4e9a\u5386\u514b\u65af\u6208\u5c14\u65af\u57fa\uff08Alex Gorsky\uff09\u6301\u76f8\u540c\u770b\u6cd5\uff0c\u4ed6\u79f0\u4e2d\u56fd\u836f\u54c1\u5ba1\u6279\u5e73\u5747\u9700\u8981\u516b\u5e74\u65f6\u95f4\uff0c\u76f8\u6bd4\u4e4b\u4e0b\u5176\u4ed6\u5e02\u573a\u53ea\u8981\u56db\u5e74\u3002\u4ed6\u4eec\u8ba4\u4e3a\u4e2d\u56fd\u533b\u836f\u5e02\u573a\u957f\u671f\u4ee5\u6765\u4e00\u76f4\u88ab\u76d1\u7ba1\u95ee\u9898\u548c\u5ba1\u6279\u6548\u7387\u4f4e\u4e0b\u6240\u56f0\u6270\uff0c\u4e2d\u56fd\u653f\u5e9c\u5e94\u8be5\u505a\u51fa\u66f4\u591a\u52aa\u529b\u6765\u6574\u987f\u524d\u666f\u5e7f\u9614\u7684\u4e2d\u56fd\u533b\u836f\u5e02\u573a\u3002<\/p>\n<p style=\"text-align: justify\">\n<p>[hide for= &#8220;!logged&#8221;]<\/p>\n<p style=\"text-align: justify\">\u5317\u4eac\u65f6\u95f411\u670811\u65e5\u4e0b\u5348\u6d88\u606f\uff0c\u4e16\u754c\u77e5\u540d\u836f\u4f01\u793c\u6765\u5236\u836f\uff08Eli Lilly\uff09\u548c\u5f3a\u751f\u5236\u836f\uff08Johnson &amp; Johnson\uff09\u7684\u9996\u5e2d\u6267\u884c\u5b98\u8fd1\u65e5\u8868\u793a\uff0c\u4e2d\u56fd\u533b\u836f\u5e02\u573a\u957f\u671f\u4ee5\u6765\u4e00\u76f4\u88ab\u76d1\u7ba1\u95ee\u9898\u548c\u5ba1\u6279\u6548\u7387\u4f4e\u4e0b\u6240\u56f0\u6270\uff0c\u5bf9\u6b64\u4ed6\u4eec\u8868\u793a\u4e2d\u56fd\u653f\u5e9c\u5e94\u8be5\u505a\u51fa\u66f4\u591a\u52aa\u529b\u6765\u6574\u987f\u524d\u666f\u5e7f\u9614\u7684\u4e2d\u56fd\u533b\u836f\u5e02\u573a\u3002<\/p>\n<p style=\"text-align: justify\">\u793c\u6765\u5236\u836f\u9996\u5e2d\u6267\u884c\u5b98\u674e\u52b1\u8fbe\uff08John C. Lechleiter\uff09\u5468\u4e00\u518d\u4e9a\u592a\u7ecf\u5408\u7ec4\u7ec7\uff08APEC\uff09\u5de5\u5546\u9886\u5bfc\u4eba\u5cf0\u4f1a\u4e0a\u8868\u793a\uff0c\u7531\u4e8e\u9762\u4e34\u76d1\u7ba1\u4e0a\u7684\u91cd\u91cd\u56f0\u96be\uff0c\u56fd\u9645\u836f\u4f01\u5f88\u96be\u5c06\u521b\u65b0\u836f\u54c1\u63a8\u5411\u4e2d\u56fd\u5e02\u573a\u3002APEC\u5de5\u5546\u9886\u5bfc\u4eba\u5cf0\u4f1a\u662f\u4e0e\u5317\u4eac\u53ec\u5f00\u7684APEC\u9886\u5bfc\u4eba\u975e\u6b63\u5f0f\u4f1a\u8bae\u6302\u94a9\u7684\u4e00\u4e2a\u6d3b\u52a8\u3002<\/p>\n<p style=\"text-align: justify\">\u674e\u52b1\u8fbe\u8bf4\uff1a\u201c\u6211\u4eec\u4eca\u5929\u4ecd\u611f\u5230\u62c5\u5fc3\u7684\u662f\u836f\u54c1\u5ba1\u6279\u4e0a\u7684\u65f6\u95f4\u6ede\u540e\uff0c\u4e2d\u56fd\u7684\u836f\u54c1\u5ba1\u6279\u6bd4\u5176\u4ed6\u5730\u65b9\u957f\u6570\u5e74\u65f6\u95f4\u3002\u201d\u5728\u53e6\u5916\u4e00\u4e2a\u91c7\u8bbf\u4e2d\uff0c\u5f3a\u751f\u9996\u5e2d\u6267\u884c\u5b98\u4e9a\u5386\u514b\u65af\u6208\u5c14\u65af\u57fa\uff08Alex Gorsky\uff09\u6301\u76f8\u540c\u770b\u6cd5\uff0c\u4ed6\u79f0\u4e2d\u56fd\u836f\u54c1\u5ba1\u6279\u5e73\u5747\u9700\u8981\u516b\u5e74\u65f6\u95f4\uff0c\u76f8\u6bd4\u4e4b\u4e0b\u5176\u4ed6\u5e02\u573a\u53ea\u8981\u56db\u5e74\u3002<\/p>\n<p style=\"text-align: justify\">\u6b27\u7f8e\u4f01\u4e1a\u8fd1\u671f\u7eb7\u7eb7\u62b1\u6028\u4e2d\u56fd\u5bf9\u5916\u4f01\u7684\u76d1\u7ba1\u592a\u8fc7\u4e25\u82db\uff0c\u4f46\u4e2d\u56fd\u5b98\u5458\u5e76\u4e0d\u8fd9\u6837\u8ba4\u4e3a\uff0c\u4ed6\u4eec\u8ba4\u4e3a\u8fd9\u6837\u505a\u662f\u4e3a\u4e86\u66f4\u597d\u7684\u4fdd\u62a4\u6d88\u8d39\u8005\u5229\u76ca\u3002\u793c\u6765\u548c\u5f3a\u751f\u8fd1\u671f\u5747\u8fdb\u5165\u4e86\u63a5\u53d7\u76d1\u7ba1\u5ba1\u67e5\u4f01\u4e1a\u540d\u5355\uff0c\u5e76\u4e14\u8be5\u540d\u5355\u8fd8\u5728\u4e0d\u65ad\u5730\u6269\u5927\u3002\u76ee\u524d\uff0c\u4e2d\u56fd\u653f\u5e9c\u52a0\u5f3a\u4e86\u7269\u4ef7\u76d1\u7763\u4e3e\u63aa\uff0c\u89e6\u89d2\u5df2\u7ecf\u4f38\u81f3\u4ece\u5236\u836f\u5230\u773c\u955c\u5230\u6c7d\u8f66\u7b49\u5404\u9886\u57df\u3002\u5728\u4e2d\u56fd\uff0c\u5236\u836f\u884c\u4e1a\u53d7\u5230\u4e86\u5c24\u5176\u4e25\u683c\u7684\u76d1\u7763\u3002\u653f\u5e9c\u8bd5\u56fe\u6839\u9664\u533b\u9662\u4e43\u81f3\u6574\u4e2a\u533b\u7597\u884c\u4e1a\u7684\u8d3f\u8d42\u548c\u8150\u8d25\u95ee\u9898\u3002<\/p>\n<p style=\"text-align: justify\">\u6208\u5c14\u65af\u57fa\u8bf4\uff0c\u5f3a\u751f\u516c\u53f8\u5728\u5927\u591a\u6570\u9886\u57df\u548c\u4e2d\u56fd\u672c\u571f\u516c\u53f8\u4eab\u53d7\u540c\u6837\u7684\u5730\u4f4d\uff0c\u4f46\u5728\u5176\u4ed6\u9886\u57df\uff0c\u5f88\u660e\u663e\u6211\u4eec\u4e0d\u5f97\u4e0d\u4e0e\u4e2d\u56fd\u5b98\u5458\u5408\u4f5c\uff0c\u624d\u80fd\u786e\u4fdd\u4eab\u53d7\u5230\u540c\u7b49\u673a\u4f1a\u3002<\/p>\n<p style=\"text-align: justify\">\u4eca\u5e749\u6708\u4efd\uff0c\u4e2d\u56fd\u4e00\u5bb6\u6cd5\u9662\u88c1\u5b9a\u82f1\u56fd\u5236\u836f\u516c\u53f8\u845b\u5170\u7d20\u53f2\u514b\uff08GlaxoSmithKline\uff09\u5728\u534e\u9644\u5c5e\u4f01\u4e1a\u884c\u8d3f\u5e76\u5bf9\u5176\u5904\u4ee5\u8fd15\u4ebf\u7f8e\u5143\u7684\u7f5a\u6b3e\u3002\u5305\u62ec\u845b\u5170\u7d20\u53f2\u514b\u524d\u4e2d\u56fd\u533a\u4e1a\u52a1\u4e3b\u7ba1\u5728\u5185\u7684\u8be5\u516c\u53f8\u4e94\u540d\u7ba1\u7406\u4eba\u58eb\u88ab\u5224\u884c\u8d3f\u7b49\u7f6a\u540d\u6210\u7acb\u5e76\u88ab\u5224\u5904\u6709\u671f\u5f92\u5211\u7f13\u671f\u6267\u884c\u3002<\/p>\n<p style=\"text-align: justify\">\u8be5\u6848\u4ee4\u4e2d\u56fd\u533b\u7597\u7cfb\u7edf\u6210\u4e3a\u4e00\u4e2a\u5173\u6ce8\u7126\u70b9\u3002\u4e13\u5bb6\u4eec\u8868\u793a\uff0c\u5728\u4e2d\u56fd\u533b\u7597\u7cfb\u7edf\u5185\u6709\u5927\u91cf\u6536\u5165\u8f83\u4f4e\u7684\u533b\u751f\u548c\u8d44\u91d1\u4e0d\u8db3\u7684\u533b\u9662\uff0c\u8fd9\u4e3a\u8d2a\u6c61\u98ce\u6c14\u7684\u5f62\u6210\u521b\u9020\u4e86\u6761\u4ef6\u3002\u4e2d\u56fd\u533b\u9662\u7684\u5927\u90e8\u5206\u6536\u5165\u6765\u81ea\u4e8e\u836f\u54c1\u9500\u552e\uff0c\u8fd9\u79cd\u60c5\u51b5\u5df2\u7ecf\u5bfc\u81f4\u5927\u91cf\u95ee\u9898\uff0c\u5305\u62ec\u8fc7\u91cf\u5f00\u836f\u548c\u533b\u751f\u63a5\u53d7\u56de\u6263\u7b49\u3002<\/p>\n<p style=\"text-align: justify\">\u674e\u52b1\u8fbe\u548c\u6208\u5c14\u65af\u57fa\u5747\u8868\u793a\uff0c\u8fc7\u53bb\u51e0\u5e74\u4e2d\u56fd\u5728\u533b\u7597\u4fdd\u5065\u6539\u9769\u65b9\u9762\u5df2\u53d6\u5f97\u8fdb\u5c55\uff0c\u6269\u5927\u4e86\u60a3\u8005\u83b7\u5f97\u533b\u7597\u670d\u52a1\u7684\u6e20\u9053\uff0c\u8fd9\u4e3a\u5236\u836f\u4f01\u4e1a\u4eec\u63d0\u4f9b\u4e86\u5e02\u573a\u673a\u4f1a\u3002\u674e\u52b1\u8fbe\u79f0\uff0c\u4e2d\u56fd\u653f\u5e9c\u5b98\u5458\u4eec\u660e\u786e\u8868\u8fbe\u4e86\u5bf9\u533b\u9662\u884c\u4e1a\u8fdb\u884c\u6574\u987f\u7684\u610f\u613f\uff0c\u4e0d\u8fc7\u76f8\u5173\u52aa\u529b\u9762\u4e34\u56f0\u96be\u3002<\/p>\n<p style=\"text-align: justify\">\u674e\u52b1\u8fbe\u8bf4\uff0c\u793c\u6765\u516c\u53f8\u5728\u4e2d\u56fd\u5949\u516c\u5b88\u6cd5\u5e76\u4e14\u5bf9\u76d1\u7ba1\u673a\u6784\u7ed9\u4e88\u5168\u529b\u914d\u5408\u3002\u53bb\u5e74\uff0c\u793c\u6765\u516c\u53f8\u4e00\u540d\u524d\u5458\u5de5\u79f0\uff0c\u8be5\u516c\u53f8\u6d89\u5acc\u5728\u534e\u884c\u8d3f\uff0c\u8be5\u516c\u53f8\u4e3a\u6b64\u8fdb\u884c\u4e86\u8c03\u67e5\u3002\u6b64\u524d\u4e00\u5bb6\u4e2d\u6587\u62a5\u7eb8\u4e5f\u66fe\u5bf9\u793c\u6765\u5728\u534e\u884c\u8d3f\u7684\u4e8b\u60c5\u6709\u8fc7\u62a5\u9053\u3002\u674e\u52b1\u8fbe\u5bf9\u76f8\u5173\u8c03\u67e5\u4e0d\u4e88\u7f6e\u8bc4\u3002<\/p>\n<p style=\"text-align: justify\">\u53e6\u4e00\u5bb6\u8de8\u56fd\u533b\u836f\u5de8\u5934\u5f3a\u751f\u8fd1\u5e74\u6765\u5728\u4e2d\u56fd\u906d\u9047\u6fc0\u70c8\u7ade\u4e89\uff0c\u672c\u5730\u548c\u56fd\u9645\u7ade\u4e89\u5bf9\u624b\u5927\u91cf\u6d8c\u5165\uff0c\u9500\u552e\u5a74\u5e7c\u513f\u4ea7\u54c1\u548c\u533b\u7597\u5668\u68b0\u3002\u4fb5\u6743\u548c\u4e13\u5229\u4fdd\u62a4\u7b49\u6311\u6218\u5df2\u7ecf\u4ee4\u8be5\u516c\u53f8\u5728\u534e\u4e1a\u52a1\u906d\u9047\u632b\u6298\u3002\u4eca\u5e745\u6708\uff0c\u6570\u5bb6\u9690\u5f62\u773c\u955c\u516c\u53f8\u56e0\u6d89\u5acc\u4ef7\u683c\u5784\u65ad\u88ab\u7f5a\u6b3e\u903e\u4eba\u6c11\u5e011900\u4e07\u5143\uff08\u5408300\u4e07\u7f8e\u5143\uff09\uff0c\u5f3a\u751f\u516c\u53f8\u4e5f\u662f\u5176\u4e2d\u4e4b\u4e00\uff0c\u88ab\u7f5a\u4e86360\u4e07\u5143\u3002<\/p>\n<p style=\"text-align: justify\">\u6208\u5c14\u65af\u57fa\u8bf4\uff0c\u5f3a\u751f\u7684\u76ee\u6807\u662f\u91c7\u7528\u6070\u5f53\u7684\u65b9\u5f0f\u8fdb\u884c\u7ade\u4e89\u3002\u4ed6\u8865\u5145\u8bf4\uff0c\u5f3a\u751f\u4e0e\u653f\u5e9c\u548c\u5ba2\u6237\u5408\u4f5c\u521b\u9020\u4e00\u4e2a\u516c\u5e73\u7684\u7ade\u4e89\u73af\u5883\uff0c\u8fd9\u6837\u5927\u5bb6\u90fd\u80fd\u4ee5\u75c5\u4eba\u548c\u5ba2\u6237\u4e3a\u51fa\u53d1\u70b9\uff0c\u5e76\u6309\u7167\u4e00\u5957\u5171\u540c\u6807\u51c6\u5f00\u5c55\u4e89\u3002<\/p>\n<p style=\"text-align: justify\">\u5728\u4e2d\u56fd\uff0c\u533b\u7597\u4fdd\u5065\u4e1a\u52a1\u589e\u901f\u8fc5\u731b\uff0c\u8d8a\u6765\u8d8a\u5bcc\u88d5\u7684\u6d88\u8d39\u8005\u5bfb\u6c42\u66f4\u597d\u7684\u533b\u7597\u6761\u4ef6\uff0c\u800c\u653f\u5e9c\u8feb\u4e8e\u516c\u4f17\u538b\u529b\u9700\u8981\u6269\u5927\u4f20\u7edf\u7684\u793e\u4f1a\u4fdd\u969c\u4f53\u7cfb\u3002\u4e24\u4f4d\u9ad8\u7ba1\u5747\u8868\u793a\u4e2d\u56fd940\u4ebf\u7f8e\u5143\u7684\u533b\u836f\u5e02\u573a\u76f8\u5f53\u5e9e\u5927\uff0c\u5bf9\u4e8e\u8de8\u56fd\u836f\u4f01\u7684\u5438\u5f15\u529b\u53ef\u60f3\u800c\u77e5\u3002\u6839\u636e\u9ea6\u80af\u9521\u7684\u6570\u636e\uff0c\u52302020\u5e74\u4e2d\u56fd\u7684\u533b\u7597\u4fdd\u5065\u5f00\u652f\u5c06\u8fbe\u52301\u4e07\u4ebf\u7f8e\u5143\u3002<\/p>\n<p>[\/hide]<\/p>\n<p style=\"text-align: justify\">\n","protected":false},"excerpt":{"rendered":"<p>John C. Lechleiter, the CEO of Eli Lilly, said on 10th, November at the APEC CEO summit that it is hard for transnational pharmaceutical companies to promote new medicine to [&hellip;]<\/p>\n","protected":false},"author":1001,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"c2c_always_allow_admin_comments":false,"footnotes":""},"categories":[2,5],"tags":[14,17,24],"class_list":["post-1332","post","type-post","status-publish","format-standard","hentry","category-government-news","category-pharmaceutical-company-news","tag-drug-supply-chain","tag-government-supervision","tag-pharmacy-management"],"_links":{"self":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/1332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/users\/1001"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/comments?post=1332"}],"version-history":[{"count":0,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/1332\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/media?parent=1332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/categories?post=1332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/tags?post=1332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}